|
Model Number SILSPT5 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Abscess (1690); Unspecified Infection (1930); Peritonitis (2252); Injury (2348); Blood Loss (2597); No Code Available (3191)
|
Event Date 10/20/2016 |
Event Type
Injury
|
Manufacturer Narrative
|
Title: ecspect prospective multicentre registry for single-port laparoscopic colorectal procedures author(s): h.Weiss1, r.Zorron4, k.-h.Vestweber5, b.Vestweber5, l.Boni6, w.Brunner8, c.Sietses9, s.Morales conde10, o.Bulut11, k.Gash12, a.R.Dixon12, c.Mittermair1, a.Klaus2, o.Stanger1, m.Weiss1, a.Muratore7 and t.Hell3, on behalf of the ecspect study group year: 2017 (b)(4).If information is provided in the future, a supplemental report will be issued.(b)(4).
|
|
Event Description
|
According to the literature source, the study was to evaluate the safety and feasibility of single-port colorectal surgery.Consecutive patients undergoing single-port colorectal surgery were enrolled from 11 european centers between march 2010 and march 2014.Some 1769 patients were enrolled, 937 with benign and 832 with malignant conditions.Conversion to open surgery was required in 75 patients.Intraoperative complications were observed in 29 patients which include; bleeding in 13 patients, injury to the urinary tract in 7 patients, enterotomy in 5 patients, and splenectomy (owing to laceration, 1).It was also noted that seven of these patients, the operation was converted to open surgery.Postoperative complications were observed in 224 patients, which were presented by complication grade/classification; an anastomotic leak, diffuse peritonitis with the presence of fecal fluid at reoperation, presence of a local abscess in the vicinity of the anastomosis; or fecal discharge from the drain or wounds.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Event Description
|
According to the literature source, the study was to evaluate the safety and feasibility of single-port colorectal surgery.Consecutive patients undergoing single-port colorectal surgery were enrolled from 11 european centers between march 2010 and march 2014.Some 1769 patients were enrolled, 937 with benign and 832 with malignant conditions.Post-operatively, 46 patients had surgical-site infection.
|
|
Search Alerts/Recalls
|
|
|